Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells.
Ammoscato F, Wafa M, Skonieczna J, Bestwick J, Monero R, Andrews M, De Trane S, Holden D, Adams A, Bianchi L, Turner B, Marta M, Schmierer K, Baker D, Giovannoni G, Gnanapavan S.
Ammoscato F, et al. Among authors: bestwick j.
Clin Immunol. 2024 Dec;269:110380. doi: 10.1016/j.clim.2024.110380. Epub 2024 Oct 18.
Clin Immunol. 2024.
PMID: 39428028
Free article.